Carmell Co. (NASDAQ:CTCX – Get Free Report) saw a significant increase in short interest in the month of June. As of June 15th, there was short interest totalling 39,400 shares, an increase of 11.0% from the May 31st total of 35,500 shares. Based on an average daily trading volume, of 11,100 shares, the days-to-cover ratio is presently 3.5 days. Approximately 0.3% of the company’s stock are short sold.
Carmell Stock Performance
CTCX stock traded up $0.31 during trading on Monday, hitting $1.64. 33,076 shares of the company’s stock traded hands, compared to its average volume of 9,080. The business has a fifty day simple moving average of $2.10 and a two-hundred day simple moving average of $2.79. Carmell has a 1 year low of $1.11 and a 1 year high of $13.31.
Carmell (NASDAQ:CTCX – Get Free Report) last issued its quarterly earnings data on Wednesday, May 15th. The company reported ($0.16) earnings per share (EPS) for the quarter.
Hedge Funds Weigh In On Carmell
Carmell Company Profile
Carmell Corporation operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Its Carmell Secretome consists of growth factors and proteins extracted from allogeneic human platelets sourced from tissue banks. The company also developed a microemulsion formulation that enables delivery of lipophilic and hydrophilic ingredients without relying on the Foul Fourteen, 14 potentially harmful excipients that are commonly used by other companies to impart texture, stability, and other desirable physicochemical attributes to cosmetic products.
See Also
- Five stocks we like better than Carmell
- 3 Best Fintech Stocks for a Portfolio Boost
- These Top 3 Banks Raise Dividends After Passing Fed Stress Test
- Stock Analyst Ratings and Canadian Analyst Ratings
- Hitch a Ride with Lyft Stock for Double-Digit Gains in 2nd Half
- Best Stocks Under $5.00
- Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market
Receive News & Ratings for Carmell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carmell and related companies with MarketBeat.com's FREE daily email newsletter.